UnitedHealth Group stock trades at EUR 329.90 before earnings

Published on 09/30/2026 at 13:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UnitedHealth Group stock heads into its October 13 earnings release after Q2 EPS of USD 6.38 beat the USD 4.94 consensus. Fiscal 2026 EPS guidance is USD 19.50-20.00.

Fotorealistisches Krankenhaus-Außengebäude bei Sonnenuntergang mit Glasfassade und Fußgängern — UnitedHealth Group US91324P1021 zeigt modernes Krankenhaus im Sonnenuntergang mit Glasfassade und Besuchern, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) was trading at EUR 329.90 at Lang & Schwarz on September 30, 2026, at 1:12 p.m. CEST, down 0.12 percent versus the prior close of EUR 330.30. The next test arrives on October 13, when the healthcare group is scheduled to report third-quarter results before the US market opens.

October 13 brings the next test

According to UnitedHealth Group on September 15, 2026, third-quarter financial results will be released on October 13, 2026, before the market opens, followed by an 8:00 a.m. ET conference call. That date gives investors a defined checkpoint for medical costs, Medicare Advantage performance and the company's full-year outlook.

The upcoming report follows a second-quarter earnings beat. MarketBeat reported on September 18, 2026, that UnitedHealth delivered EPS of USD 6.38 for the quarter, above the USD 4.94 consensus estimate, while revenue reached USD 112.03 billion versus USD 110.81 billion expected.

Guidance raises the stakes

Management's fiscal 2026 EPS guidance is USD 19.50-20.00, the same MarketBeat report said. The comparison is important because second-quarter EPS exceeded consensus by USD 1.44, while revenue was USD 1.22 billion above the estimate.

For investors, the central question is whether the earnings beat can translate into durable margin improvement. UnitedHealth's second-quarter figures provide evidence of stronger near-term execution, but the October report will show whether that performance supports the full-year range rather than remaining a single-quarter result.

Stock stays below its yearly high

UnitedHealth Group had a market capitalization of USD 340.5 billion on September 29, 2026. Its 52-week range was USD 255.97 to USD 461.62, placing the latest primary-market reference below the yearly high and leaving the October earnings release as the next dated company event.

Lang and Schwarz price on September 30

UnitedHealth Group stock was trading at EUR 329.90 at Lang & Schwarz on September 30, 2026, at 1:12 p.m. CEST, down 0.12 percent versus the Lang & Schwarz prior close of EUR 330.30 on September 29, 2026.